Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$791,623
+$200,549 QoQ
Shares Held
660
+20.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#3,339
of 4,605 holders
Holding Since
Jun 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Advisors Preferred, LLC holds $5,804,895 across 5 Drug Manufacturers - General names. LLY ranks #3 (13.6% of the industry book) .
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $791,623 | 660 | Shares | Other | 2026-08-11 | |
| 2025-12-31 | $591,074 | 550 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $419,650 | 550 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $2,650,402 | 3,400 | Shares | Other | 2025-08-05 | |
| 2025-03-31 | $2,808,094 | 3,400 | Shares | Other | 2025-05-06 | |
| 2023-12-31 | $7,577 | 13 | Shares | Other | 2024-01-24 | |
| 2023-09-30 | $11,279 | 21 | Shares | Other | 2023-11-07 | |
| 2023-06-30 | $468,979 | 1,000 | Shares | Other | 2023-08-04 | |
| 2023-03-31 | $498,989 | 1,453 | Shares | Other | 2023-05-03 | |
| 2021-09-30 | $417,738 | 1,808 | Shares | Other | 2021-10-27 | |
| 2021-06-30 | $406,479 | 1,771 | Shares | Other | 2021-07-26 | |
| 2021-03-31 | $443,323 | 2,373 | Shares | Other | 2021-05-07 | |
| 2020-12-31 | $289,560 | 1,715 | Shares | Other | 2021-02-03 | |
| 2020-09-30 | $371,086 | 2,507 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $244,792 | 1,491 | Shares | Other | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||